CGDI Deputy Director Dr. Maria Puiu talks about mitochondrial replacement therapy

Modern genomic technologies, such as mitochondrial replacement therapy, offer new possibilities for preventing mother-to-child transmission of inherited diseases. 

Although this is an approved method in a limited number of countries, in discussion with SmartLiving, Prof. Dr. Maria Puiu, Deputy Director of the CGDI, emphasizes the importance of accurate information on such topics, which contributes to a better understanding of the medical options available to support health.

Controversial procedure allowed in England, banned in other countries. Prof. Dr. Maria Puiu, geneticist at the Genomics Research Institute: "Let's understand how healthy babies are born with three parents"

Follow the link below to find out more from the interview: 

Controversial procedure allowed in England, banned in the US. Prof. Dr. Maria Puiu, geneticist at the Institute for Genomics Research: "Let's understand how healthy babies are born with three parents"